AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12173196 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg orally every 8 h the day before surgery and 75 mg i.m. every 12 h on the day of surgery)
Number of subjects: 46
Study 9443711 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine 32 mg daily
Number of subjects: 297
Study 9443711 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine 56 mg daily
Number of subjects: 297
Study 9443711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 9443711 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine 16 mg daily
Number of subjects: 297
Study 8536511 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Papillary Dilation (EPD)
Number of subjects: 20
Study 8536511 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic Sphincterotomy (EST)
Number of subjects: 20
Study 2379255 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous inoculation with DPT and BCG vaccines
Number of subjects: 0
Study 2379255 — intervention group
Group type: COMPARATOR
Intervention: DPT alone
Number of subjects: 0
Study 2379255 — intervention group
Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 0
Study 31354 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 78
Study 31354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 30820923 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution based on autonomy
Number of subjects: 0
Study 30820923 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution based on coercion
Number of subjects: 0
Study 30820923 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution based on reciprocity
Number of subjects: 0
Study 30820923 — intervention group
Group type: EXPERIMENTAL
Intervention: Salience of patients' need
Number of subjects: 0
Study 28835400 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral angioplasty/stenting plus best medical treatment (BMT)
Number of subjects: 182
Study 28835400 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment (BMT) alone
Number of subjects: 182
Study 28835400 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral angioplasty/stenting plus BMT
Number of subjects: 182
Study 26424639 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT + Adapted CBSST
Number of subjects: 0
Study 26424639 — intervention group
Group type: COMPARATOR
Intervention: ACT alone
Number of subjects: 0
Study 23796582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin 200 mg b.i.d. for 10 days
Number of subjects: 100
Study 23796582 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 125 mg q.i.d. for 10 days
Number of subjects: 100
Study 23796582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (fidaxomicin and vancomycin)
Number of subjects: 100
Study 21835296 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antihypertensive therapy (thiazide and potassium-sparing diuretic; thiazide and angiotensin-converting enzyme inhibitor)
Number of subjects: 161585
Study 21835296 — intervention group
Group type: COMPARATOR
Intervention: Single-drug initial therapy
Number of subjects: 161585
Study 19843489 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of valsartan 160 mg
Number of subjects: 38
Study 19843489 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of valsartan 160 mg
Number of subjects: 38
Study 16912020 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 60
Study 16912020 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 60
Study 16912020 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 15212193 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotaverine capsule preparation (20 mg Droxa mite)
Number of subjects: 23
Study 15212193 — intervention group
Group type: COMPARATOR
Intervention: Reference tablet preparation
Number of subjects: 23
Study 10895885 — intervention group
Group type: EXPERIMENTAL
Intervention: Validly cued trials
Number of subjects: 0
Study 10895885 — intervention group
Group type: COMPARATOR
Intervention: Invalidly cued trials
Number of subjects: 0
Study 10895885 — intervention group
Group type: COMPARATOR
Intervention: Neutrally cued trials
Number of subjects: 0
Study 10895885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued conditions (valid and neutral)
Number of subjects: 0
Study 10895885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tests of integrality
Number of subjects: 0
Study 10895885 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative correlated change for frequency
Number of subjects: 0
Study 9059680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine at 3 mg/kg/day
Number of subjects: 41
Study 9059680 — intervention group
Group type: COMPARATOR
Intervention: Topical betamethasone-17,21-dipropionate
Number of subjects: 41
Study 7839936 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle, unilateral breast stimulation
Number of subjects: 300
Study 7839936 — intervention group
Group type: COMPARATOR
Intervention: Control group (no breast stimulation)
Number of subjects: 300
Study 7839936 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle, unilateral breast stimulation (cross-over trial)
Number of subjects: 300
Study 7839936 — intervention group
Group type: COMPARATOR
Intervention: Control group (ex-study)
Number of subjects: 300
Study 7839936 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle, unilateral breast stimulation (in multiparous patients)
Number of subjects: 300
Study 7839936 — intervention group
Group type: COMPARATOR
Intervention: Control group (in multiparous patients)
Number of subjects: 300
Study 3527592 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 1 g Neomycin plus 0.25 g Metronidazole t.i.d. on the last preoperative day
Number of subjects: 2
Study 3527592 — intervention group
Group type: COMPARATOR
Intervention: Intravenous single dose 5 g Mezlocillin plus 0.5 g Metronidazole
Number of subjects: 2
Study 2840050 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride
Number of subjects: 65
Study 2840050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 31772117 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomised trials of health programmes
Number of subjects: 0
Study 31772117 — intervention group
Group type: COMPARATOR
Intervention: Research ethics review
Number of subjects: 0
Study 31217257 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 32
Study 31217257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 28830491 — intervention group
Group type: EXPERIMENTAL
Intervention: BioLex®-GLM (600 mg daily)
Number of subjects: 80
Study 28830491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 26074424 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative condition (write about a heavy drinking event that was negative)
Number of subjects: 429
Study 26074424 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive condition (write about a heavy drinking event that was positive)
Number of subjects: 429
Study 26074424 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition (write about their first day of college)
Number of subjects: 429
Study 23333189 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional quantitative ultrasound (QUS)
Number of subjects: 290
Study 20921028 — intervention group
Group type: COMPARATOR
Intervention: Spasticity assessment at all time points (6, 12, 24, 36 weeks)
Number of subjects: 30
Study 20921028 — intervention group
Group type: COMPARATOR
Intervention: Functional recovery assessment (ARAT)
Number of subjects: 30
Study 20921028 — intervention group
Group type: COMPARATOR
Intervention: Contracture assessment
Number of subjects: 30
Study 19482378 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG): standard health intervention
Number of subjects: 1104
Study 19482378 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention and a program of home blood pressure monitoring (EG)
Number of subjects: 1104
Study 19482378 — intervention group
Group type: EXPERIMENTAL
Intervention: Card control intervention and HBPM programme (CHG)
Number of subjects: 1104
Study 19482378 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention, card control and HBPM programme (ECHG)
Number of subjects: 1104
Study 16564374 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel surgical protocol including uvulaflap, tonsillectomy, hyoid suspension, and radiofrequency treatment of the tongue base (group A)
Number of subjects: 60
Study 16564374 — intervention group
Group type: COMPARATOR
Intervention: Surgery without hyoid suspension (group B)
Number of subjects: 60
Study 12771457 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 200
Study 12771457 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 200
Study 10709814 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural tremor with no visual feedback
Number of subjects: 51
Study 10709814 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremor in Parkinson's disease
Number of subjects: 51
Study 10709814 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger flexions
Number of subjects: 51
Study 10709814 — intervention group
Group type: EXPERIMENTAL
Intervention: Time domain characteristics
Number of subjects: 51
Study 10709814 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceleration data
Number of subjects: 51
Study 9357885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine at concentrations of 0.3 ng/ml and 0.6 ng/ml
Number of subjects: 9
Study 9357885 — intervention group
Group type: COMPARATOR
Intervention: Control values (baseline)
Number of subjects: 9
Study 9357885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 9
Study 8096945 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukotriene LTE4 inhalation
Number of subjects: 4
Study 8096945 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 4
Study 3803701 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate spray (2.5 mg, 2 squirts, administered 2 min before testing)
Number of subjects: 10
Study 3803701 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 10
Study 29927891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sled towing with 35% reduction in velocity
Number of subjects: 12
Study 29927891 — intervention group
Group type: COMPARATOR
Intervention: Sled towing with 55% reduction in velocity
Number of subjects: 12
Study 29927891 — intervention group
Group type: COMPARATOR
Intervention: Baseline unresisted 20‐m sprints
Number of subjects: 12
Study 29927891 — intervention group
Group type: COMPARATOR
Intervention: Unresisted 20‐m sprints at 2, 4, 6, 8, 12, and 16 minutes
Number of subjects: 12
Study 29927891 — intervention group
Group type: COMPARATOR
Intervention: EMG assessment
Number of subjects: 12
Study 29571817 — intervention group
Group type: EXPERIMENTAL
Intervention: mOPV2 doses at 1 week interval (n=191)
Number of subjects: 760
Study 29571817 — intervention group
Group type: EXPERIMENTAL
Intervention: mOPV2 doses at 2 weeks interval (n=191)
Number of subjects: 760
Study 29571817 — intervention group
Group type: COMPARATOR
Intervention: mOPV2 doses at 4 weeks interval (n=188)
Number of subjects: 760
Study 29571817 — intervention group
Group type: EXPERIMENTAL
Intervention: mOPV2 doses at 4 weeks interval plus IPV (n=190)
Number of subjects: 760
Study 27530156 — intervention group
Group type: EXPERIMENTAL
Intervention: Group nurse-led consultations (4 group sessions and 1 individual consultation)
Number of subjects: 331
Study 27530156 — intervention group
Group type: COMPARATOR
Intervention: Usual care (individual consultations)
Number of subjects: 331
Study 27530156 — intervention group
Group type: EXPERIMENTAL
Intervention: Group nurse-led consultations
Number of subjects: 331
Study 26652724 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of aerobic exercise
Number of subjects: 46
Study 26652724 — intervention group
Group type: COMPARATOR
Intervention: Reading control
Number of subjects: 46
Study 23748210 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug (AAD) therapy
Number of subjects: 154
Study 23748210 — intervention group
Group type: COMPARATOR
Intervention: Reablation (repulmonary vein isolation)
Number of subjects: 154
Study 19788955 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report by phone
Number of subjects: 140
Study 19788955 — intervention group
Group type: COMPARATOR
Intervention: Home inventory
Number of subjects: 140
Study 18802911 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive dual-incision approach
Number of subjects: 40
Study 18802911 — intervention group
Group type: COMPARATOR
Intervention: Standard posterolateral approach
Number of subjects: 40
Study 16626384 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-lightening gel with ultrasound
Number of subjects: 60
Study 16626384 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60
Study 16626384 — intervention group
Group type: COMPARATOR
Intervention: Skin-lightening gel treatment
Number of subjects: 60
Study 12694345 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 3000
Study 12694345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study 10024108 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion (20% of total calories)
Number of subjects: 23
Study 10024108 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion + 1.8 g/day EPA
Number of subjects: 23
Study 10024108 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion
Number of subjects: 23
Study 10024108 — intervention group
Group type: COMPARATOR
Intervention: Fat-free TPN (Control)
Number of subjects: 23
Study 7775683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 0
Study 7775683 — intervention group
Group type: COMPARATOR
Intervention: Behavioral management group (Control)
Number of subjects: 0
Study 2279535 — intervention group
Group type: EXPERIMENTAL
Intervention: PGI2 (5 ng/kg/min i.v.)
Number of subjects: 0
Study 2279535 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE1 (1 ng/kg/min i.a.)
Number of subjects: 0
Study 2279535 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PGI2 and PGE1
Number of subjects: 0
Study 2279535 — intervention group
Group type: EXPERIMENTAL
Intervention: Second infusion of the same compound
Number of subjects: 0
Study 6101677 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) 60 microgram/day
Number of subjects: 0
Study 6101677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31566810 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatar application
Number of subjects: 70
Study 31566810 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 70
Study 29589050 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based feedback-controlled active muscle training programme
Number of subjects: 60
Study 29589050 — intervention group
Group type: COMPARATOR
Intervention: Control group (identical postoperative protocol without active muscle training)
Number of subjects: 60
Study 27897018 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable single-incision (Ajust) tape
Number of subjects: 100
Study 27897018 — intervention group
Group type: COMPARATOR
Intervention: Standard transobturator midurethral sling (TVT-O)
Number of subjects: 100
Study 25131348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) with a goal of ≥7% reduction in baseline weight
Number of subjects: 1701
Study 25131348 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher fiber intake (8.3 g/day increase)
Number of subjects: 1701
Study 25131348 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline intake of fruit
Number of subjects: 1701
Study 25131348 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline intake of high-fiber grain and cereal
Number of subjects: 1701
Study 25131348 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (control arm)
Number of subjects: 1701
Study 23021325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1261
Study 23021325 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1261
Study 20176418 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support
Number of subjects: 124
Study 20176418 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 124
Study 17270513 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly supervised pulmonary rehabilitation (2 sessions/week)
Number of subjects: 91
Study 17270513 — intervention group
Group type: COMPARATOR
Intervention: Once-weekly supervised pulmonary rehabilitation (1 session/week)
Number of subjects: 91
Study 16093405 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-washed soy protein concentrate
Number of subjects: 159
Study 16093405 — intervention group
Group type: COMPARATOR
Intervention: Milk-protein based control
Number of subjects: 159
Study 16093405 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during run-in period
Number of subjects: 159
Study 16093405 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during intervention period
Number of subjects: 159
Study 12174159 — intervention group
Group type: EXPERIMENTAL
Intervention: Methenamine hippurate (1 g Hiprex, twice daily for 5 days)
Number of subjects: 145
Study 12174159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 9869506 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg, t.d.s.)
Number of subjects: 34
Study 9869506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (10 mg, o.d.)
Number of subjects: 34
Study 7989628 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 percent EMLA cream
Number of subjects: 20
Study 7989628 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 percent lidocaine ointment
Number of subjects: 20
Study 7989628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2919600 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 21
Study 2919600 — intervention group
Group type: COMPARATOR
Intervention: Aluminum hydroxide
Number of subjects: 21
Study 29154368 — intervention group
Group type: EXPERIMENTAL
Intervention: naltrexone
Number of subjects: 426
Study 29154368 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 426
Study 28793967 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm (advanced type 2 specialty clinic model)
Number of subjects: 60
Study 28793967 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard endocrinology clinics)
Number of subjects: 60
Study 25697763 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) therapy
Number of subjects: 25
Study 25697763 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryo-ultrasound (cryo-US) therapy
Number of subjects: 25
Study 25697763 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 25
Study 25697763 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study 23427839 — intervention group
Group type: EXPERIMENTAL
Intervention: Group treatment using manualized hypnosis
Number of subjects: 85
Study 23427839 — intervention group
Group type: COMPARATOR
Intervention: Individual treatment using manualized hypnosis
Number of subjects: 85
Study 21297442 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 120
Study 21297442 — intervention group
Group type: COMPARATOR
Intervention: Placebo-saline
Number of subjects: 120
Study 19363107 — intervention group
Group type: EXPERIMENTAL
Intervention: Color My Pyramid nutrition education program
Number of subjects: 126
Study 16834789 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (50 mg kg‐1 in 100 mL of isotonic saline over 20 min)
Number of subjects: 30
Study 16834789 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline over the same period)
Number of subjects: 30
Study 16834789 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate
Number of subjects: 30
Study 16834789 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 15320640 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional plus stretching (S)
Number of subjects: 83
Study 15320640 — intervention group
Group type: COMPARATOR
Intervention: Traditional (T) warm-up
Number of subjects: 83
Study 11308246 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report questionnaire (GHQ12) completed by patients prior to consultation
Number of subjects: 2297
Study 11308246 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors' visual analogue scales rating patients' distress after consultation
Number of subjects: 2297
Study 9305483 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral elemental diet (Peptamen, Clintec, USA) for 2 weeks
Number of subjects: 22
Study 9305483 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids for 2 weeks
Number of subjects: 22
Study 7584283 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphemic encoding
Number of subjects: 0
Study 7584283 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic encoding
Number of subjects: 0
Study 7584283 — intervention group
Group type: COMPARATOR
Intervention: Standard indirect test
Number of subjects: 0
Study 7584283 — intervention group
Group type: COMPARATOR
Intervention: Direct test
Number of subjects: 0
Study 2572741 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid (3.5 g)
Number of subjects: 6
Study 2572741 — intervention group
Group type: COMPARATOR
Intervention: Stearic acid
Number of subjects: 6
Study 2572741 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil (30 g, predominantly diunsaturated)
Number of subjects: 6
Study 2572741 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil (30 g, predominantly monounsaturated)
Number of subjects: 6
Study 2572741 — intervention group
Group type: EXPERIMENTAL
Intervention: Suet (30 g, predominantly saturated)
Number of subjects: 6